v3.25.2
Stock Compensation Plan (Tables)
6 Months Ended
Jun. 30, 2025
Stock Compensation Plan  
Schedule of Company's Stock Options

The following table sets forth the activity for the Company’s stock options during the periods presented:

 

 

Number of
Options

 

 

Weighted-
Average
Exercise
Price
per Share

 

 

Weighted
Average
Remaining
Contractual
Term
(in Years)

 

 

Aggregate
Intrinsic
Value

 

Outstanding as of December 31, 2024

 

 

2,731,000

 

 

$

1.90

 

 

 

7.4

 

 

$

7,171,930

 

Granted

 

 

 

 

$

 

 

 

 

 

 

 

Forfeited

 

 

(300,000

)

 

$

2.00

 

 

 

 

 

 

 

Outstanding as of June 30, 2025

 

 

2,431,000

 

 

$

1.89

 

 

 

6.9

 

 

$

13,292,660

 

Exercisable as of June 30, 2025

 

 

2,429,519

 

 

$

1.89

 

 

 

6.9

 

 

$

13,284,722

 

Vested or expected to vest as of June 30, 2025

 

 

2,431,000

 

 

$

1.89

 

 

 

6.9

 

 

$

13,292,660

 

Schedule of Summarizes Vesting of Restricted Common Stock

The following table summarizes vesting of restricted common stock:

 

 

Number of
Shares

 

 

Weighted
Average Grant
Date Fair
Value
Per Share

 

Unvested as of December 31, 2024

 

 

2,814,703

 

 

$

3.24

 

Granted

 

 

2,923,783

 

 

$

6.55

 

Vested

 

 

(984,330

)

 

$

4.73

 

Unvested as of June 30, 2025

 

 

4,754,156

 

 

$

4.97

 

Schedule of Stock-Based Compensation Expense

Stock-based compensation expense for all stock awards recognized in the accompanying consolidated statements of operations and comprehensive loss is as follows:

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Selling, general and administrative

 

$

4,379,090

 

 

$

2,436,295

 

 

$

6,198,189

 

 

$

4,066,886

 

Research and development

 

 

50,587

 

 

 

81,721

 

 

 

121,189

 

 

 

164,784

 

Total

 

$

4,429,677

 

 

$

2,518,016

 

 

$

6,319,378

 

 

$

4,231,670